Most cited article - PubMed ID 31192324
Effects of in vivo conditions on amyloid aggregation
Mounting evidence suggests that the neuronal cell membrane is the main site of oligomer-mediated neuronal toxicity of amyloid-β peptides in Alzheimer's disease. To gain a detailed understanding of the mutual interference of amyloid-β oligomers and the neuronal membrane, we carried out microseconds of all-atom molecular dynamics (MD) simulations on the dimerization of amyloid-β (Aβ)42 in the aqueous phase and in the presence of a lipid bilayer mimicking the in vivo composition of neuronal membranes. The dimerization in solution is characterized by a random coil to β-sheet transition that seems on pathway to amyloid aggregation, while the interactions with the neuronal membrane decrease the order of the Aβ42 dimer by attenuating its propensity to form a β-sheet structure. The main lipid interaction partners of Aβ42 are the surface-exposed sugar groups of the gangliosides GM1. As the neurotoxic activity of amyloid oligomers increases with oligomer order, these results suggest that GM1 is neuroprotective against Aβ-mediated toxicity.
- Keywords
- Alzheimer’s disease, amyloid-β, molecular dynamics, neuronal membrane, transition network,
- MeSH
- Amyloid chemistry MeSH
- Amyloid beta-Peptides chemistry metabolism MeSH
- Cell Membrane metabolism MeSH
- G(M1) Ganglioside metabolism MeSH
- Protein Conformation MeSH
- Humans MeSH
- Lipid Bilayers metabolism MeSH
- Protein Multimerization * MeSH
- Neurons metabolism MeSH
- Molecular Dynamics Simulation MeSH
- Protein Binding MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Amyloid MeSH
- Amyloid beta-Peptides MeSH
- G(M1) Ganglioside MeSH
- Lipid Bilayers MeSH
Aβ, IAPP, α-synuclein, and prion proteins belong to the amyloidogenic intrinsically disordered proteins' family; indeed, they lack well defined secondary and tertiary structures. It is generally acknowledged that they are involved, respectively, in Alzheimer's, Type II Diabetes Mellitus, Parkinson's, and Creutzfeldt-Jakob's diseases. The molecular mechanism of toxicity is under intense debate, as many hypotheses concerning the involvement of the amyloid and the toxic oligomers have been proposed. However, the main role is represented by the interplay of protein and the cell membrane. Thus, the understanding of the interaction mechanism at the molecular level is crucial to shed light on the dynamics driving this phenomenon. There are plenty of factors influencing the interaction as mentioned above, however, the overall view is made trickier by the apparent irreproducibility and inconsistency of the data reported in the literature. Here, we contextualized this topic in a historical, and even more importantly, in a future perspective. We introduce two novel insights: the chemical equilibrium, always established in the aqueous phase between the free and the membrane phospholipids, as mediators of protein-transport into the core of the bilayer, and the symmetry-breaking of oligomeric aggregates forming an alternating array of partially ordered and disordered monomers.
- Keywords
- CMC, amyloids, intrinsically disordered proteins, lipid, lipid-assisted protein transport, lipids, membrane, protein-transport, symmetry-breaking, toxicity,
- Publication type
- Journal Article MeSH
- Review MeSH